Related Articles
The combination of paclitaxel and carboplatin as second-line chemotherapy can be a preferred regimen for patients with urothelial carcinoma after the failure of gemcitabine and cisplatin chemotherapy
Chemotherapy for urothelial carcinoma in renal transplantation patients: Initial results from a single center
A pilot study of paclitaxel and carboplatin for recurrent ovarian cancer
Prognostic nutritional index of early post‑pembrolizumab therapy predicts long‑term survival in patients with advanced urothelial carcinoma
Efficacy of platinum-based chemotherapy after cranial radiation in patients with brain metastasis from non-small cell lung cancer